Physician profile
James Mcnerney
NPI 1144381443
$930.59
in general payments reported to CMS, 2019-2025
9 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $94.92 · 2021: $198 · 2022: $54.23 · 2023: $241 · 2024: $224 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $327.92 | 2022-2025 | Floseal, Perclot |
| Musculoskeletal Transplant Foundation INC. | $218.22 | 2021-2023 | |
| Lifenet Health | $104.62 | 2023 | |
| Organogenesis INC. | $98.95 | 2021 | |
| Stryker Corporation | $70.62 | 2020 | |
| Smith+Nephew, INC. | $49.49 | 2025 | Grafix Pl, Oasis |
| Misonix INC | $24.30 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $18.95 | 2025 | |
| Kci USA, INC. | $17.52 | 2023 | V.A.C.Ulta, Prevena, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcnerney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.